Xencor reported $6.54M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Cytokinetics USD 10.25M 2.75M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Xencor USD 6.54M 710K Sep/2025